NK cell conversion into intermediate ILC1 or ILC1-like cells in the presence of TGF-β was associated with increased CD96 together with reduced DNAM-1 expression in mouse tumor models [161], likely driving the observed impairment of the anti-tumor immune response. This evidence concerns the gene CD96 and neoplasm.